Exelon

In the US, Exelon (rivastigmine systemic) is a member of the drug class cholinesterase inhibitors and is used to treat Alzheimer's Disease and Parkinson's Disease.

US matches:

• Exelon


• Exelon Patch


• Exelon Solution


• Exelon Transdermal

UK matches:

• Exelon 4.6 mg/24h and 9.5 mg/24h transdermal patch (SPC)

Ingredient matches for Exelon

Rivastigmine

Rivastigmine is reported as an ingredient of Exelon in the following countries:

• Austria


• Croatia (Hrvatska)


• Finland


• France


• Germany


• Sweden


• Switzerland


• Tunisia


• Turkey


• United Kingdom

Rivastigmine tartrate (a derivative of Rivastigmine) is reported as an ingredient of Exelon in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Bangladesh


• Belgium


• Bulgaria


• Canada


• Chile


• China


• Colombia


• Czech Republic


• Denmark


• Ecuador


• Finland


• France


• Greece


• Hong Kong


• Hungary


• Iceland


• India


• Indonesia


• Ireland


• Israel


• Italy


• Luxembourg


• Malaysia


• Mexico


• Netherlands


• New Zealand


• Norway


• Oman


• Peru


• Philippines


• Portugal


• Romania


• Russian Federation


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sri Lanka


• Sweden


• Switzerland


• Taiwan


• Thailand


• United Kingdom


• United States


• Venezuela

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.